LBF20207PG41: Difference between revisions

No edit summary
 
(19 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}


Line 4: Line 6:
|LipidBank=XPR1772
|LipidBank=XPR1772
|LipidMaps=LMFA03010102
|LipidMaps=LMFA03010102
|SysName=9a,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid
|SysName=(9S,15R) -Dihydroxy-11-oxo- (cis-5,trans-13) -prostadienoic acid
|Common Name=&&15 (R) -Prostaglandin D2&&
|Common Name=&&15(R) - Prostaglandin D_2&&(9S,15R) -Dihydroxy-11-oxo- (5Z,13E) -prostadienoic acid&&(9alpha,15R) -Dihydroxy-11-oxo-prosta- (5Z,13E) -dien-1-oic acid&&
 
|Source=
|Chemical Synthesis=
|Metabolism=
|Biological Activity=15(R)-PGD2 is reported to have potent agonistic effect to the DP2 receptor 5 time higher than PGD2.[[Reference:Giles_H:Leff_P:Bolofo_ML:Kelly_MG:Robertson_AD:,Br. J. Pharmacol.,1989,96,291|{{RelationTable/GetFirstAuthor|Reference:Giles_H:Leff_P:Bolofo_ML:Kelly_MG:Robertson_AD:,Br. J. Pharmacol.,1989,96,291}}]]
}}
}}
{{Lipid/Footer}}

Latest revision as of 03:13, 2 November 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



15(R) - Prostaglandin D2
LBF20207PG41.png
Structural Information
(9S,15R) -Dihydroxy-11-oxo- (cis-5,trans-13) -prostadienoic acid
  • 15(R) - Prostaglandin D2
  • (9S,15R) -Dihydroxy-11-oxo- (5Z,13E) -prostadienoic acid
  • (9α,15R) -Dihydroxy-11-oxo-prosta- (5Z,13E) -dien-1-oic acid
Formula C20H32O5
Exact Mass 352.224974134
Average Mass 352.46508
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC
Physicochemical Information
15(R)-PGD2 is reported to have potent agonistic effect to the DP2 receptor 5 time higher than PGD2. Giles_H et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG41 See above. Giles_H et al. 1989